Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Strides Pharma Macrogol

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Ethylene Glycol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 332,050Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5Forlax

    02 1Fortrans

    03 3Fortrans/Eziclen

    04 2Movicol

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Forlax

    Macrogol

    arrow
    PPS Boston
    Not Confirmed

    Brand Name : Forlax

    France
    arrow
    PPS Boston
    Not Confirmed

    Ipsen

    Macrogol

    Main Therapeutic Indication : Gastrointestinal Disorders

    Currency : USD

    2020 Revenue in Millions : 47

    2019 Revenue in Millions : 51

    Growth (%) : -7

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Fortrans/Eziclen

    Macrogol

    arrow
    PPS Boston
    Not Confirmed

    Brand Name : Fortrans/Eziclen

    France
    arrow
    PPS Boston
    Not Confirmed

    Ipsen

    Macrogol

    Main Therapeutic Indication : Gastrointestinal Disorders

    Currency : USD

    2020 Revenue in Millions : 34

    2019 Revenue in Millions : 45

    Growth (%) : -24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Fortrans/Eziclen

    Macrogol

    arrow
    PPS Boston
    Not Confirmed

    Brand Name : Fortrans/Eziclen

    France
    arrow
    PPS Boston
    Not Confirmed

    Ipsen

    Macrogol

    Main Therapeutic Indication : Gastrointestinal Disorders

    Currency : USD

    2021 Revenue in Millions : 40

    2020 Revenue in Millions : 34

    Growth (%) : 28

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Forlax

    Macrogol

    arrow
    PPS Boston
    Not Confirmed

    Brand Name : Forlax

    France
    arrow
    PPS Boston
    Not Confirmed

    Ipsen

    Macrogol

    Main Therapeutic Indication : Gastrointestinal Disorders

    Currency : USD

    2021 Revenue in Millions : 40

    2020 Revenue in Millions : 47

    Growth (%) : -8

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Movicol

    Polyethylene Glycol

    arrow
    PPS Boston
    Not Confirmed

    Brand Name : Movicol

    Japan
    arrow
    PPS Boston
    Not Confirmed

    Eisai

    Polyethylene Glycol

    Main Therapeutic Indication : Gastrointestinal Diseases

    Currency : USD

    2022 Revenue in Millions : 71

    2021 Revenue in Millions : 0

    Growth (%) : 100

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Movicol

    Polyethylene Glycol

    arrow
    PPS Boston
    Not Confirmed

    Brand Name : Movicol

    Japan
    arrow
    PPS Boston
    Not Confirmed

    Eisai

    Polyethylene Glycol

    Main Therapeutic Indication : Gastrointestinal Diseases

    Currency : USD

    2023 Revenue in Millions : 35

    2022 Revenue in Millions : 44

    Growth (%) : -12

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Forlax

    Macrogol (aka polyethlene glycol)

    arrow
    PPS Boston
    Not Confirmed

    Brand Name : Forlax

    France
    arrow
    PPS Boston
    Not Confirmed

    Ipsen

    Macrogol (aka polyethlene glycol)

    Main Therapeutic Indication : Others

    Currency : USD

    2015 Revenue in Millions : 43

    2014 Revenue in Millions : 44

    Growth (%) : 2%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Fortrans

    Macrogol

    arrow
    PPS Boston
    Not Confirmed

    Brand Name : Fortrans

    France
    arrow
    PPS Boston
    Not Confirmed

    Ipsen

    Macrogol

    Main Therapeutic Indication : Gastrointestinal Disorders

    Currency : USD

    2016 Revenue in Millions : 24

    2015 Revenue in Millions : 25

    Growth (%) : -4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Forlax

    Macrogol

    arrow
    PPS Boston
    Not Confirmed

    Brand Name : Forlax

    France
    arrow
    PPS Boston
    Not Confirmed

    Ipsen

    Macrogol

    Main Therapeutic Indication : Gastrointestinal Disorders

    Currency : USD

    2016 Revenue in Millions : 41

    2015 Revenue in Millions : 42

    Growth (%) : -3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Fortrans/Eziclen

    Macrogol

    arrow
    PPS Boston
    Not Confirmed

    Brand Name : Fortrans/Eziclen

    France
    arrow
    PPS Boston
    Not Confirmed

    Ipsen

    Macrogol

    Main Therapeutic Indication : Gastrointestinal Disorders

    Currency : USD

    2019 Revenue in Millions : 40

    2018 Revenue in Millions : 34

    Growth (%) : 17

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF